scholarly journals Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics

Molecules ◽  
2020 ◽  
Vol 25 (18) ◽  
pp. 4053
Author(s):  
Hamid Heydari Sheikh Hossein ◽  
Iraj Jabbari ◽  
Atefeh Zarepour ◽  
Ali Zarrabi ◽  
Milad Ashrafizadeh ◽  
...  

In recent years, the intrinsic magnetic properties of magnetic nanoparticles (MNPs) have made them one of the most promising candidates for magnetic resonance imaging (MRI). This study aims to evaluate the effect of different coating agents (with and without targeting agents) on the magnetic property of MNPs. In detail, iron oxide nanoparticles (IONPs) were prepared by the polyol method. The nanoparticles were then divided into two groups, one of which was coated with silica (SiO2) and hyperbranched polyglycerol (HPG) (SPION@SiO2@HPG); the other was covered by HPG alone (SPION@HPG). In the following section, folic acid (FA), as a targeting agent, was attached on the surface of nanoparticles. Physicochemical properties of nanostructures were characterized using Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM), and a vibrating sample magnetometer (VSM). TEM results showed that SPION@HPG was monodispersed with the average size of about 20 nm, while SPION@SiO2@HPG had a size of about 25 nm. Moreover, HPG coated nanoparticles had much lower magnetic saturation than the silica coated ones. The MR signal intensity of the nanostructures showed a relation between increasing the nanoparticle concentrations inside the MCF-7 cells and decreasing the signal related to the T2 relaxation time. The comparison of coating showed that SPION@SiO2@HPG (with/without a targeting agent) had significantly higher r2 value in comparison to Fe3O4@HPG. Based on the results of this study, the Fe3O4@SiO2@HPG-FA nanoparticles have shown the best magnetic properties, and can be considered promising contrast agents for magnetic resonance imaging applications.

Author(s):  
Alina S. Korsakova ◽  
Dzmitry A. Kotsikau ◽  
Yulyan S. Haiduk ◽  
Vladimir V. Pankov

Ferrimagnetic nanoparticles are used in biotechnology (as drug carriers, biosensors, elements of diagnostic sets, contrast agents for magnetic resonance imaging), catalysis, electronics, and for the production of magnetic fluids and magnetorheological suspensions, etc. The use of magnetic nanoparticles requires enhanced magnetic characteristics, in particular, high saturation magnetisation.The aim of our study was to obtain single-phased magnetic nanoparticles of MnxFe3–xO4 solid solutions at room temperature. We also studied the dependence of the changes in their structure, morphology, and magnetic properties on the degree of substitution in order to determine the range of the compounds with the highest magnetisation value.A number of powders of Mn-substituted magnetite MnxFe3–xO4 (x = 0 – 1.8) were synthesized by means of co-precipitation from aqueous solutions of salts. The structural and micro-structural features and magnetic properties of the powders were studied using magnetic analysis, X-ray diffraction, transmission electron microscopy, and IR spectroscopy.The X-ray phase analysis and IR spectroscopy confirm the formation of single-phase compounds with cubic spinel structures. The maximum increase in saturation magnetization as compared to non-substituted magnetite was observed for Mn0.3Fe2.7O4 (Ms = 68 A·m2·kg–1 at 300 K and Ms = 85 A·m2·kg–1 at 5 K). This is associated with the changes in the cation distribution between the tetrahedral and octahedral cites.A method to control the magnetic properties of magnetite by the partial replacement of iron ions in the magnetite structure with manganese has been proposed in the paper. The study demonstrated that it is possible to change the magnetisation and coercivity of powders by changing the degree of substitution. The maximum magnetisation corresponds to the powder Mn0.3Fe2.7O4. The nanoparticles obtained by the proposed method have a comparatively high specific magnetisation and a uniform size distribution. Therefore the developed materials can be used for the production of magnetorheological fluidsand creation of magnetically controlled capsules for targeted drug delivery and disease diagnostics in biology and medicine (magnetic resonance imaging).       References1. Gubin C. G., Koksharov Yu. A., Khomutov G. B.,Yurkov G. Yu. Magnetic nanoparticles: preparation,structure and properties. Russian Chemical Reviews2005;74(6): 539–574. Available at: https://www.elibrary.ru/item.asp?id=90858192. Skumr yev V. , Stoyanov S. , Zhang Y. ,Hadjipanayis G., Givord D., Nogués J. Beating thesuperparamagnetic limit with exchange bias. Nature.2003;423(6943): 850–853. DOI: https://doi.org/10.1038/nature016873. Joseph A., Mathew S. Ferrofluids: syntheticstrategies, stabilization, physicochemical features, characterization, and applications. ChemPlusChem.2014;79(10): 1382–1420. DOI: https://doi.org/10.1002/cplu.2014022024. Mathew D. S., Juang R.-S. An overview of thestructure and magnetism of spinel ferrite nanoparticlesand their synthesis in microemulsions. ChemicalEngineering Journal. 2007:129(1–3): 51–65. DOI:https://doi.org/10.1016/j.cej.2006.11.0015. Rewatkar K. G. Magnetic nanoparticles:synthesis and properties. Solid State Phenomena.2016:241: 177–201. DOI: https://doi.org/10.4028/www.scientific.net/ssp.241.1776. Tartaj P., Morales M. P., Veintemillas-VerdaguerS., Gonzalez-Carre´no T., Serna C. J. Thepreparation of magnetic nanoparticles for applicationsin biomedicine. Journal of Physics D: Applied Physics.2003: 36 (13): 182–197. DOI: : https://doi.org/10.1088/0022-3727/36/13/2027. West A. Khimiya tverdogo tela. Teoriya iprilozheniya [Solid State Chemistry and Its Applications].In 2 parts Part 1. Transl. from English. Moscow, Mir,1988 558 p.8. Spravochnik khimika: V 6 t. 2-e izd. Obshchiyesvedeniya. Stroyeniye veshchestva. Svoystva vazhneyshikhveshchestv. Laboratornaya tekhnika [Chemist’sHandbook: In 6 volumes, 2nd ed. General information.The structure of matter. Properties of the mostimportant substances. Laboratory equipment]. B. P.Nikolskiy (ed.) Moscow – Leningrad: GoskhimizdatPubl.; 1963. V. 1. 1071 p. (In Russ.)9. Zhuravlev G. I. Khimiya i tekhnologiya ferritov[Ferrite chemistry and technology]. Leningrad:Khimiya Publ.; 1970. p. 192. (In Russ.)10. Mason B. Mineralogical aspects of the systemFeO-Fe2O3-MnO-Mn2O3. Geologiska Föreningen iStockholm Förhandlingar. 1943;65(2): 97–180. DOI:https://doi.org/10.1080/1103589430944714211. Guillemet-Fritsch S., Navrotsky A., TailhadesPh., Coradin H., Wang M. Thermochemistry of ironmanganese oxide spinels. Journal of Solid StateChemistry. 2005;178(1):106–113. DOI: https://doi.org/10.1016/j.jssc.2004.10.03112. Ortega D. Structure and magnetism in magneticnanoparticles. In: Magnetic Nanoparticles: FromFabrication to Clinical Applications. Boca Raton: CRCPress; 2012. p. 3–72. DOI:https://doi.org/10.1201/b11760-313. Kodama T., Ookubo M., Miura S., Kitayama Y.Synthesis and characterization of ultrafine Mn(II)-bearing ferrite of type MnxFe3-xO4 by coprecipitation.Materials Research Bulletin... 1996:31(12): 1501–1512.DOI: https://doi.org/10.1016/s0025-5408(96)00146-814. Al-Rashdi K. S., Widatallah H., Al Ma’Mari F.,Cespedes O., Elzain M., Al-Rawas A., Gismelseed A.,Yousif A. Structural and mossbauer studies ofnanocrystalline Mn2+ doped Fe3O4 particles. HyperfineInteract. 2018:239(1): 1–11. DOI: https://doi.org/10.1007/s10751-017-1476-915. Modaresi N., Afzalzadeh R., Aslibeiki B.,Kameli P. Competition between the Impact of cationdistribution and crystallite size on properties ofMnxFe3–xO4 nanoparticles synthesized at roomtemperature. Ceramics International. 2017:43(17):15381–15391. DOI: https://doi.org/10.1016/j.ceramint.2017.08.079


2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Ling Chen ◽  
Jun Xie ◽  
Haoan Wu ◽  
Jianzhong Li ◽  
Zhiming Wang ◽  
...  

Developing a biocompatible contrast agent with high stability and favorable magnetism for sensitive detection of malignant tumors using magnetic resonance imaging (MRI) remains a great demand in clinical. Nowadays, the fine control of magnetic iron oxide nanoparticle (MION) sizes from a few nanometers to dozens of nanometers can be realized through a thermal decomposition method of iron precursors. This progress allows us to research accurately on the size dependence of magnetic properties of MION, involving saturation magnetization (Ms), specific absorption rate (SAR), and relaxivity. Here, we synthesized MION in a size range between 14 and 26 nm and modified them with DSPE-PEG2000 for biomedical use. The magnetic properties of PEGylated MION increased monotonically with MION size, while the nonspecific uptake of MION also enhanced with size through cell experiments. The MION with the size of 22 nm as a T2-weighted contrast agent presented the best contrast-enhancing effect comparing with other sizes in vivo MRI of murine tumor. Therefore, the MION of 22 nm may have potential to serve as an ideal MRI contrast agent for tumor detection.


2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
David Kovář ◽  
Aneta Malá ◽  
Jitka Mlčochová ◽  
Michal Kalina ◽  
Zdenka Fohlerová ◽  
...  

Magnetic nanoparticles produced using aqueous coprecipitation usually exhibit wide particle size distribution. Synthesis of small and uniform magnetic nanoparticles has been the subject of extensive research over recent years. Sufficiently small superparamagnetic iron oxide nanoparticles easily permeate tissues and may enhance the contrast in magnetic resonance imaging. Furthermore, their unique small size also allows them to migrate into cells and other body compartments. To better control their synthesis, a chemical coprecipitation protocol was carefully optimised regarding the influence of the injection rate of base and incubation times. The citrate-stabilised particles were produced with a narrow average size range below 2 nm and excellent stability. The stability of nanoparticles was monitored by long-term measurement of zeta potentials and relaxivity. Biocompatibility was tested on the Caki-2 cells with good tolerance. The application of nanoparticles for magnetic resonance imaging (MRI) was then evaluated. The relaxivities (r1,r2) and r2/r1 ratio calculated from MR images of prepared phantoms indicate the nanoparticles as a promising T2-contrast probe.


2021 ◽  
Vol 20 ◽  
pp. 153303382110365
Author(s):  
Lin Qiu ◽  
Shuwen Zhou ◽  
Ying Li ◽  
Wen Rui ◽  
Pengfei Cui ◽  
...  

Bifunctional magnetic/fluorescent core-shell silica nanospheres (MNPs) encapsulated with the magnetic Fe3O4 core and a derivate of 8-amimoquinoline (N-(quinolin-8-yl)-2-(3-(triethoxysilyl) propylamino) acetamide) (QTEPA) into the shell were synthesized. These functional MNPs were prepared with a modified stöber method and the formed Fe3O4@SiO2-QTEPA core-shell nanocomposites are biocompatible, water-dispersible, and stable. These prepared nanoparticles were characterized by X-ray power diffraction (XRD), transmission electron microscopy (TEM), thermoelectric plasma Quad II inductively coupled plasma mass spectrometry (ICP-MS), superconducting quantum interference device (SQUID), TG/DTA thermal analyzer (TGA) and Fourier transform infrared spectroscopy (FTIR). Further application of the nanoparticles in detecting Zn2+ was confirmed by the fluorescence experiment: the nanosensor shows high selectivity and sensitivity to Zn2+ with a 22-fold fluorescence emission enhancement in the presence of 10 μM Zn2+. Moreover, the transverse relaxivity measurements show that the core-shell MNPs have T2 relaxivity (r2) of 155.05 mM−1 S−1 based on Fe concentration on the 3.0 T scanner, suggesting that the compound can be used as a negative contrast agent for MRI. Further in vivo experiments showed that these MNPs could be used as MRI contrast agent. Therefore, the new nanosensor provides the dual modality of magnetic resonance imaging and optical imaging.


2017 ◽  
Vol 8 (34) ◽  
pp. 5157-5166 ◽  
Author(s):  
A. V. Fuchs ◽  
A. P. Bapat ◽  
G. J. Cowin ◽  
K. J. Thurecht

A switchable polymeric 19F magnetic resonance imaging (MRI) contrast agent was synthesised whereby the transverse (T2) relaxation times increased as a therapeutic was released from a hyperbranched polymer (HBP) scaffold.


Sign in / Sign up

Export Citation Format

Share Document